Medicaid removes cost barriers to breast cancer screening for millions
H.R. 8729 — No-Cost Breast Examinations in Medicaid Act of 2026 · Filed by Greg Landsman (D-OH) · 1 cosponsor · Introduced May 11, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires Medicaid to cover breast cancer screening and diagnostic examinations—including mammograms, ultrasounds, and MRI scans—without any cost-sharing (copays, coinsurance, or deductibles) for beneficiaries. It applies to both routine screening mammograms and supplemental exams for people at higher risk, as well as diagnostic exams to evaluate abnormalities. Ordinary Medicaid enrollees benefit by gaining free access to these preventive and diagnostic breast cancer services.
Why we flagged it
The bill's core function is to expand Medicaid coverage of breast cancer screening and diagnostic services as a preventive health benefit, removing cost barriers for low-income beneficiaries. This is straightforward public health policy, not a tax provision, subsidy, or commemorative measure.
What the text implies
- Increased demand for breast imaging services (mammography, ultrasound, MRI) may strain capacity at imaging centers serving Medicaid populations, potentially creating access delays in underserved areas.
- The bill ties coverage definitions to National Comprehensive Cancer Network Guidelines and USPSTF grades, creating ongoing regulatory dependency on external standard-setting bodies rather than explicit statutory criteria.
The full analysis lists 3 implications of this text.
Who stands to gain
diagnostic imaging providers (radiology centers, hospitals); medical device manufacturers (ultrasound, MRI equipment); healthcare systems with breast imaging programs